Skip to main content

Dialysing the Elderly Patient with Congestive Heart Failure: What Is Important to Know?

  • Chapter
  • First Online:
Dialysis in Older Adults
  • 775 Accesses

Abstract

The number of elderly patients surviving with increasing and more complex co-morbidity, especially in affluent countries, continues to grow exponentially. Elderly patients with the combination of chronic kidney disease stage 5 and congestive heart failure (CHF) have an increased risk of death. They should, if possible, be empowered to choose between conservative supportive care and dialysis. In countries without well-developed supportive palliative care programs, greater numbers of elderly patients with high co-morbidity scores, including CHF, withdraw from dialysis within the first few months of starting treatment [1]. This is particularly true for haemodialysis (HD). It is worth noting that a 4 h HD session may well expand into 8–10 h day, with the patient feeling too exhausted to do anything but to simply go to straight to bed on final arrival at home [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Chan HW, Clayton PA, McDonald SP, Agar JW, Jose MD (2012) Risk factors for dialysis withdrawal: an analysis of the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, 1999-2008. Clin J Am Soc Nephrol 7(5):775–781

    Article  PubMed  Google Scholar 

  2. Carson RC, Juszczak M, Davenport A, Burns A (2009) Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin J Am Soc Nephrol 4(10):1611–1619

    Article  PubMed  PubMed Central  Google Scholar 

  3. European Society of Cardiology Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC (2012) Eur Heart J 33:1787–1847

    Google Scholar 

  4. USRDS annual data report: atlas of chronic kidney disease and end-stage renal disease in the US National Institutes of Health, Diabetes and Digestive and Kidney Diseases 2007, Bethesda

    Google Scholar 

  5. Bleyer AJ, Hartman J, Brannon PC, Reeves-Daniel A, Satko SG, Russell G (2006) Characteristics of sudden death in haemodialysis patients. Kidney Int 69:2268–2273

    Article  CAS  PubMed  Google Scholar 

  6. CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316:1429–1435

    Article  Google Scholar 

  7. The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325:293–302

    Article  Google Scholar 

  8. Matsumoto Y, Kageyama S, Yakushigawa T, Arihara K, Sugiyama T, Mori Y, Sugiyama H, Ohmura H, Shio N (2009) Long-term low-dose spironolactone therapy is safe in oligoanuric haemodialysis patients. Cardiology 114(1):32–38

    Article  CAS  PubMed  Google Scholar 

  9. Asif A, Salman LH, Lopera GG, Carrillo RG (2011) The dilemma of transvenous cardiac rhythm devices in haemodialysis patients: time to consider the epicardial approach? Kidney Int 79(12):1267–1269

    Article  PubMed  Google Scholar 

  10. Winkelmayer WC, Liu J, Setoguchi S, Choudhry NK (2011) Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol 6(11):2662–2668

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Chan KE, Lazarus JM, Thadhani R, Hakim RM (2009) Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol 20(10):2223–2233

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Lip GY, Piotrponikowski P, Andreotti F, Anker SD, Filippatos G, Homma S, Morais J, Pullicino P, Rasmussen LH, Marín F, Lane DA (2012) Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC working group on thrombosis. Thromb Haemost 108(6):1009–1022

    Article  CAS  PubMed  Google Scholar 

  13. Pamukcu B, Lip GY, Lane DA (2010) Simplifying stroke risk stratification in atrial fibrillation patients: implications of the CHA2DS2-VASc risk stratification scores. Age Ageing 39(5):533–535

    Article  PubMed  Google Scholar 

  14. Fehrman-Ekholm I, Lotsander A, Logan K, Dunge D, Odar-Cederlöf I, Kallner A (2008) Concentrations of vitamin C, vitamin B12 and folic acid in patients treated with haemodialysis and on-line haemodiafiltration or haemofiltration. Scand J Urol Nephrol 42:74–80

    Article  CAS  PubMed  Google Scholar 

  15. Cranenburg EC, Schurgers LJ, Uiterwijk HH, Beulens JW, Dalmeijer GW, Westerhuis R, Magdeleyns EJ, Herfs M, Vermeer C, Laverman GD (2012) Vitamin K intake and status are low in haemodialysis patients. Kidney Int 82(5):605–610

    Article  CAS  PubMed  Google Scholar 

  16. McKeag NA, McKinley MC, Woodside JV, Harbinson MT, McKeown PP (2012) The role of micronutrients in heart failure. J Acad Nutr Diet 112(6):870–886

    Article  CAS  PubMed  Google Scholar 

  17. Sandek A, Bjarnason I, Volk HD, Crane R, Meddings JB, Niebauer J, Kalra PR, Buhner S, Herrmann R, Springer J, Doehner W, von Haehling S, Anker SD, Rauchhaus M (2012) Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure. Int J Cardiol 157(1):80–85

    Article  PubMed  Google Scholar 

  18. Van Der Sande FM, Cnossen TT, Cornelis T, Konings CJ, Kooman JP, Leunissen KM (2012) Peritoneal dialysis in patients with heart failure. Minerva Urol Nefrol 64(3):163–172

    Google Scholar 

  19. Nakayama M (2013) Nonuremic indication for peritoneal dialysis for refractory heart failure in cardiorenal syndrome type II: review and perspective. Perit Dial Int 33(1):8–14

    Article  PubMed  PubMed Central  Google Scholar 

  20. Cnossen TT, Kooman JP, Krepel HP, Konings CJ, Uszko-Lencer NH, Leunissen KM, van der Sande FM (2012) Prospective study on clinical effects of renal replacement therapy in treatment-resistant congestive heart failure. Nephrol Dial Transplant 27(7):2794–2799

    Article  PubMed  Google Scholar 

  21. Chou MT, Wang JJ, Sun YM, Sheu MJ, Chu CC, Weng SF, Chio CC, Kan WC, Chien CC (2012) Epidemiology and mortality among dialysis patients with acute coronary syndrome: Taiwan National Cohort Study. Int J Cardiol 167(6):2719–2723

    Google Scholar 

  22. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK (2006) Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 69(7):1222–1228

    Article  CAS  PubMed  Google Scholar 

  23. Donauer J, Kölblin D, Bek M, Krause A, Böhler J (2000) Ultrafiltration profiling and measurement of relative blood volume as strategies to reduce hemodialysis-related side effects. Am J Kidney Dis 36(1):115–123

    Article  CAS  PubMed  Google Scholar 

  24. Shah A, Davenport A (2012) Does a reduction in dialysate sodium improve blood pressure control in haemodialysis patients? Nephrology (Carlton) 17(4):358–363

    Article  CAS  Google Scholar 

  25. Santoro A, Mancini E, Gaggi R, Cavalcanti S, Severi S, Cagnoli L, Badiali F, Perrone B, London G, Fessy H, Mercadal L, Grandi F (2005) Electrophysiological response to dialysis: the role of dialysate potassium content and profiling. Contrib Nephrol 149:295–305

    Article  CAS  PubMed  Google Scholar 

  26. Locatelli F, Covic A, Chazot C, Leunissen K, Luño J, Yaqoob M (2004) Optimal composition of the dialysate, with emphasis on its influence on blood pressure. Nephrol Dial Transplant 19(4):785–796

    Article  PubMed  Google Scholar 

  27. Selby NM, McIntyre CW (2006) A systematic review of the clinical effects of reducing dialysate fluid temperature. Nephrol Dial Transplant 21(7):1883–1898

    Article  PubMed  Google Scholar 

  28. Mancini E, Mambelli E, Irpinia M, Gabrielli D, Cascone C, Conte F, Meneghel G, Cavatorta F, Antonelli A, Villa G, Dal Canton A, Cagnoli L, Aucella F, Fiorini F, Gaggiotti E, Triolo G, Nuzzo V, Santoro A (2007) Prevention of dialysis hypotension episodes using fuzzy logic control system. Nephrol Dial Transplant 22(5):1420–1427

    Article  PubMed  Google Scholar 

  29. Davenport A, Cox C, Thuraisingham R (2008) Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension. Kidney Int 73(6):759–764

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew Davenport MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Davenport, A. (2016). Dialysing the Elderly Patient with Congestive Heart Failure: What Is Important to Know?. In: Misra, M. (eds) Dialysis in Older Adults. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3320-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3320-4_12

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3318-1

  • Online ISBN: 978-1-4939-3320-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics